n-methyl-3,4-methylenedioxyamphetamine has been researched along with Schizophrenia in 9 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Little is known about the effect of stimulant use (amphetamines, cocaine, ecstasy) on cognitive functioning in schizophrenia patients." | 3.80 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. ( Meijer, CJ; Meijer, JH; van den Brink, W; van der Meer, FJ; Velthorst, E, 2014) |
| "The study of drug induced dissociation is important, because it may shed light on the mechanisms involved in dissociative psychopathology." | 2.80 | MDMA, cannabis, and cocaine produce acute dissociative symptoms. ( Bosker, WM; Giesbrecht, T; Jan Verkes, R; Kuypers, KP; Merckelbach, H; Ramaekers, JG; Spronk, DB; Theunissen, EL; van Heugten-Van der Kloet, D; van Wel, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bershad, AK | 1 |
| de Wit, H | 1 |
| Thwaites, SJ | 1 |
| Gogos, A | 1 |
| Van den Buuse, M | 1 |
| van der Meer, FJ | 1 |
| Meijer, JH | 1 |
| Meijer, CJ | 1 |
| van den Brink, W | 1 |
| Velthorst, E | 1 |
| van Heugten-Van der Kloet, D | 1 |
| Giesbrecht, T | 1 |
| van Wel, J | 1 |
| Bosker, WM | 1 |
| Kuypers, KP | 1 |
| Theunissen, EL | 1 |
| Spronk, DB | 1 |
| Jan Verkes, R | 1 |
| Merckelbach, H | 1 |
| Ramaekers, JG | 1 |
| Nichols, D | 1 |
| Fischer, RB | 1 |
| Hashimoto, K | 1 |
| Schmidt, CJ | 1 |
| Kehne, JH | 1 |
| Carr, AA | 1 |
| Fadayel, GM | 1 |
| Humphreys, TM | 1 |
| Kettler, HJ | 1 |
| McCloskey, TC | 1 |
| Padich, RA | 1 |
| Taylor, VL | 1 |
| Sorensen, SM | 1 |
| Lieberman, JA | 1 |
| Mailman, RB | 1 |
| Duncan, G | 1 |
| Sikich, L | 1 |
| Chakos, M | 1 |
| Nichols, DE | 1 |
| Kraus, JE | 1 |
4 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Schizophrenia
| Article | Year |
|---|---|
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.
Topics: Adult; Apathy; Humans; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Psychopharmacology; Schiz | 2023 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; | 2008 |
Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Dopamine; Humans; N-Methyl-3,4-methylenedioxyamphetam | 1993 |
Serotonergic basis of antipsychotic drug effects in schizophrenia.
Topics: Antipsychotic Agents; Brain; Corpus Striatum; Dopamine; Humans; N-Methyl-3,4-methylenedioxyamphetami | 1998 |
1 trial available for n-methyl-3,4-methylenedioxyamphetamine and Schizophrenia
| Article | Year |
|---|---|
MDMA, cannabis, and cocaine produce acute dissociative symptoms.
Topics: Adult; Amphetamine-Related Disorders; Cannabinoids; Cocaine; Cocaine-Related Disorders; Cross-Over S | 2015 |
4 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Schizophrenia
| Article | Year |
|---|---|
Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: effect of MDMA, DOI and 8-OH-DPAT.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Evoked Potentials; Male; N-Methyl-3,4 | 2013 |
Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamines; Central Nervous System Stimulants; Cocaine; Cogni | 2014 |
Legal highs: the dark side of medicinal chemistry.
Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Huma | 2011 |
[Psychiatric illness associated with amphetamines and other stimulants].
Topics: Adult; Amnesia; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Designer Drugs | 2000 |